Accuracy and precision of four value-added blood glucose meters: The abbott optium, the DDI prodigy, the HDI true track, and the hypoguard assure pro

Diabetes Technology and Therapeutics

Volumn 11, Issue 9, 2009, Pages 587-592

  Sheffield, Catherine A ^a   Kane, Michael P ^b   Bakst, Gary ^c   Busch, Robert S ^c   Abelseth, Jill M ^c   Hamilton, Robert A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; FEMALE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VEIN PUNCTURE;

AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BLOOD SPECIMEN COLLECTION; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DIABETES MELLITUS; DIET; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TIME FACTORS; UNITED STATES;

EID: 70349306724     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0143     Document Type: Article

References (23)

1. American Diabetes Association: Self-monitoring of blood glucose (consensus statement). Diabetes Care 1994;17:81-86.
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
3. Stades AM, Hoekstra JB, van den Tweel I, Erkelens DW, Holleman F; STABILITY Study Group: Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults: a real-life design. Diabetes Care 2002;25:712-717.
4. Riddle M, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators: The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-3086.
5. Albisser AM, Sakkal S, Wright RN: Home blood glucose prediction: validation, safety, and efficacy testing in clinical diabetes. Diabetes Technol Ther 2005;7:487-496.
6. Welschen LMC, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM: Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28:1510-1517. (Pubitemid 40756728)
7. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2004;27(Suppl 1):S15-S35.
8. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13(Suppl 1):1-68.
9. Bergenstal RM, Gavin III JR; Global Consensus Conference on Glucose Monitoring Panel: The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005;118 (Suppl 9A):1S-6S.
10. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl S: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care1987;10:622-628.
11. ISO 15197 In Vitro Diagnostic Test Systems-Requirements for Blood-Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus. ISO 15197:2003(E). Geneva: International Standards Organization, 2003.
12. Parkes JL, Slatin SL, Pardo S, Ginsberg BH: A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000; 8:1143-1148.
13. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial=Epidemiology of Diabetes Interventions and Complications (DCCT=EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643-2653.
14. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853. Erratum: Lancet 1999;354:602.
15. Resnick HE, Foster GL, Bardsley J, Ratner RE: Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 2006;29:531-537.
16. GalaxoSmithKline: State of Diabetes Complications in America. http:==www.stateofdiabetes.com=blood-sugar-levels.html (accessed March 15, 2008).
17. Tunis SL, Minshall ME: Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United States. Am J Manag Care 2008;14:131-140.
18. Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV: Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care 2000;23:477-483.
19. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004;30:112-125.
20. U.S. Food and Drug Administration: Standards Program. http:==www.fda.gov=cdrh=stdsprog.html (accessed June 29, 2008).
21. Clinical and Laboratory Standards Institute (CLSI): Point-of-Care Glucose Testing in Acute and Chronic Care Facilities: Approved Guideline, 2nd ed. CLSI document C30-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2002.
22. Rivers SM, Kane MP, Busch RS, Bakst G, Hamilton RA: Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch Ultra. Am J Health Syst Pharm 2006;63:1411-1416.
23. Thomas LE, Kane MP, Bakst G, Busch RS, Hamilton RA, Abelseth JM: A glucose meter accuracy and precision comparison: the FreeStyle Flash versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour and the BD Logic. Diabetes Technol Ther 2008;10:102-110.